GlassScriptPhysician profile
Timberly Butler
NPI 1417310285
$1,987.24
in general payments reported to CMS, 2019-2025
24 companies · $666 in 2025
The $666 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $352 · 2023: $453 · 2024: $353 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.97 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $369.10 | 2023-2025 | |
| Abbvie INC. | $233.97 | 2021-2025 | Lo Loestrin Fe, Orilissa |
| Evofem Biosciences, INC. | $214.10 | 2021-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $162.83 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $150.44 | 2021-2023 | Injectafer |
| Organon LLC | $129.36 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $102.72 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $87.81 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $75.40 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $74.10 | 2021-2023 | |
| Pfizer INC. | $70.99 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $47.93 | 2025 | Myfembree |
| Hologic Sales and Service, LLC | $39.70 | 2023 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Coopersurgical, INC. | $32.39 | 2022-2024 | Paragard T 380a |
| Millicent US INC | $31.76 | 2025 | Femlyv, Intrarosa |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $30.57 | 2024 | Ova1 |
| Shield Therapeutics INC | $20.17 | 2024 | |
| Smith+Nephew, INC. | $19.52 | 2025 | Pico 14 |
| Optumhealth Care Solutions, LLC | $19.12 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pharmacosmos Therapeutics INC. | $17.24 | 2023 | Monoferric |
| Becton, Dickinson and Company | $16.97 | 2022 | |
| Kci USA, INC. | $16.92 | 2023 | Prevena |
| Alexion Pharmaceuticals, INC. | $12.81 | 2022 | |
| Acessa Health INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timberly Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.